The FRS9 Antibody is a research-grade polyclonal antibody targeting the FRS9 protein, a transcription factor implicated in circadian rhythm regulation in Arabidopsis thaliana (mouse-ear cress). This antibody is primarily used to study FRS9’s role in gene expression and its interaction with chromatin during circadian cycles .
FRS9 is a transcription factor involved in circadian gene regulation. Key discoveries include:
Phase-Specific Binding: FRS9 exhibits rhythmic chromatin binding, peaking in specific circadian phases to regulate oscillating gene expression .
Cluster-Specific Activity: FRS9 is enriched in Cluster 1, where it drives genes with expression peaks during the light phase (e.g., photosynthesis-related genes) .
Mechanistic Insight: FRS9’s binding correlates with H3K9ac histone modifications, suggesting a role in chromatin remodeling to activate circadian genes .
Co-regulation with Other TFs: FRS9 interacts with transcription factors like TCP1 and SPL11 to coordinate circadian gene networks .
Negative Regulation Potential: While FRS9 primarily activates genes, some TFs (e.g., TCP23, ERF38) exhibit inverse regulatory relationships, indicating complex feedback loops .
The FRS9 Antibody enables targeted investigations into:
Epitope Mapping: Defining FRS9’s binding sites could enhance antibody specificity and utility in ChIP-seq experiments.
Functional Knockout Models: Using CRISPR-Cas9 to generate FRS9-deficient plants, combined with antibody-based assays, could clarify its role in circadian rhythms.
Cross-Species Relevance: Investigating FRS9 homologs in other plants or model organisms to assess conserved circadian mechanisms.